Related Experiment Videos

The empiric treatment of nosocomial intra-abdominal infections

Hervé Dupont1

  • 1Pôle d'Anesthésie Réanimation, Centre Hospitalier Universitaire, Amiens, France. dupont.herve@chu-amiens.fr

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|July 10, 2007
PubMed

Insights

Choosing the right antibiotics for nosocomial intra-abdominal infections is crucial. Early, appropriate antimicrobial therapy improves outcomes and reduces mortality, especially with resistant bacteria like ESBLs and VRE.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Complicated intra-abdominal infections (IAIs) present significant treatment challenges due to their polymicrobial nature and potential for severe outcomes.
  • Inappropriate empiric antimicrobial therapy for nosocomial IAIs is linked to poorer clinical resolution, longer hospital stays, and increased mortality.
  • Increasing prevalence of multidrug-resistant organisms, including extended-spectrum beta-lactamases (ESBLs) and vancomycin-resistant enterococci (VRE), complicates treatment selection.

Purpose of the Study:

  • To discuss the advantages and disadvantages of empiric antimicrobial therapy for nosocomial IAIs.
  • To review current clinical guidelines for managing these infections.
  • To explore available therapeutic options for treating nosocomial IAIs.

Main Methods:

  • Literature review of existing studies and clinical guidelines.
  • Analysis of antimicrobial resistance patterns relevant to IAIs.
  • Discussion of therapeutic strategies and agent selection.

Main Results:

  • Empiric therapy selection is critical for successful treatment of nosocomial IAIs.
  • Physicians must consider local resistance patterns and the likelihood of encountering resistant pathogens.
  • Guidelines provide a framework, but clinical judgment is essential for optimal patient care.

Conclusions:

  • Effective management of nosocomial IAIs requires careful consideration of empiric antimicrobial therapy.
  • Anticipating and covering for resistant organisms like ESBLs and VRE is paramount.
  • Ongoing evaluation of treatment outcomes and resistance trends is necessary to refine therapeutic approaches.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...